Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer

Oxid Med Cell Longev. 2017:2017:2873030. doi: 10.1155/2017/2873030. Epub 2017 Aug 7.

Abstract

Diverse proinflammatory biomarkers and oxidative stress are strongly associated with advanced epithelial ovarian cancer (EOC). Objective. To determine the behavior of markers of oxidative stress and inflammation in plasma and ascites fluid in patients with platinum-sensitive, platinum-resistant, and platinum-refractory EOC. Methods. A prospective cohort study. The colorimetric method was used to determine levels of the markers 8-isoprostanes (8-IP), lipid peroxidation products (LPO), and total antioxidant capacity (TAC) in plasma and ascites fluid; and with ELISA, the levels of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) were determined in patients with EOC. Results. In ascites fluid, a significant increase in 8-IP versus baseline plasma levels was found (p = 0.002). There was an important leakage of the TAC levels in ascites fluid versus baseline plasma levels (p < 0.001). The IL-6 was elevated in ascites fluid versus baseline plasma levels (p = 0.003), and there were diminished levels of TNF-α in ascites fluid versus baseline plasma levels (p = 0.001). Discussion. We hypothesize that the ascites fluid influences the behavior and dissemination of the tumor. Deregulation between oxidants, antioxidants, and the proinflammatory cytokines was found to vary among platinum-sensitive, platinum-resistant, and platinum-refractory patients.

MeSH terms

  • Adult
  • Aged
  • Antioxidants / metabolism
  • Ascites / blood*
  • Biomarkers, Tumor / metabolism*
  • Carcinoma, Ovarian Epithelial
  • Drug Resistance, Neoplasm / drug effects*
  • Female
  • Humans
  • Inflammation / blood
  • Inflammation / pathology*
  • Interleukin-6 / blood
  • Isoprostanes / blood
  • Lipid Peroxides / blood
  • Middle Aged
  • Neoplasms, Glandular and Epithelial / blood*
  • Neoplasms, Glandular and Epithelial / drug therapy*
  • Neoplasms, Glandular and Epithelial / pathology
  • Ovarian Neoplasms / blood*
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / pathology
  • Oxidative Stress / drug effects*
  • Platinum / pharmacology
  • Platinum / therapeutic use*
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Antioxidants
  • Biomarkers, Tumor
  • Interleukin-6
  • Isoprostanes
  • Lipid Peroxides
  • Tumor Necrosis Factor-alpha
  • Platinum